Moxidectin for Donkeys: Deworming Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Moxidectin is a macrocyclic lactone dewormer used to control certain internal parasites. In equids, it is most commonly sold as an oral gel labeled for horses and ponies. Donkeys are often treated under your vet's direction using equine products, but that use may be extra-label depending on the product and the exact situation.

Moxidectin works by disrupting nerve signaling in susceptible parasites, which leads to paralysis and elimination. In horses and ponies, labeled oral gel products are used against large and small strongyles, pinworms, bots, and encysted small strongyles. Merck also lists moxidectin 0.4 mg/kg by mouth as a treatment option for Dictyocaulus arnfieldi lungworm in donkeys and horses.

Because donkeys can differ from horses in parasite burden, body condition, and drug handling, this is not a medication to give casually. Your vet may recommend moxidectin only after reviewing fecal egg counts, age, weight, pasture exposure, and whether your donkey is thin, sick, very young, or carrying a heavy parasite load.

Moxidectin is used as part of a targeted deworming plan, not as a one-size-fits-all routine. In equids, it is commonly chosen when your vet wants coverage for adult and larval strongyles, including encysted cyathostomes, plus bots. Combination products that add praziquantel may also be used when tapeworm coverage is needed.

For donkeys, one especially important parasite is lungworm (Dictyocaulus arnfieldi). Donkeys can carry lungworms with few signs, while horses sharing the same pasture may develop coughing or poor performance. Merck lists oral moxidectin as one treatment option for this parasite, which is one reason your vet may think about it in mixed equine herds.

Moxidectin is not ideal for every donkey. Current equine parasite-control guidance emphasizes fecal egg counts, fecal egg count reduction testing, and strategic treatment rather than frequent fixed-interval deworming or blind rotation between drug classes. Your vet may prefer another dewormer if your donkey is very young, underweight, debilitated, or if local resistance patterns make moxidectin a poor fit.

In equine oral gel products, the commonly referenced dose is 0.4 mg/kg by mouth once. FDA-listed horse and pony products and Merck's lungworm table both use that dose. Syringes are typically calibrated by body weight, so accurate weighing or a weight tape matters. Underdosing can reduce effectiveness and may encourage parasite resistance.

That said, donkey dosing should be set by your vet, not copied from a horse tube in the barn. Donkeys are often treated using horse protocols because species-specific labeled products are limited, but your vet may adjust the plan based on age, body condition, pregnancy status, fecal results, and whether tapeworm coverage is also needed.

Extra caution is needed in foals, miniature donkeys, thin donkeys, and debilitated animals. Equine labels warn that transient neurologic signs such as ataxia, incoordination, lethargy, depression, and droopy lips or eyelids may occur when very young or debilitated animals are treated. If your donkey has a heavy parasite burden, your vet may also choose a different starting approach to lower the risk of complications after deworming.

Many donkeys tolerate moxidectin well when it is used correctly, but side effects can happen. The main concerns reported in equids are temporary neurologic or sedation-like signs, including ataxia, incoordination, lethargy, depression, and droopy lips or eyelids. Mild digestive upset can also occur.

In a reproductive safety study for the equine moxidectin/praziquantel gel, one treated mare had episodes of decreased appetite, diarrhea, depression, and one colic episode that resolved without treatment. While that study was in horses rather than donkeys, it is a useful reminder to monitor closely after dosing.

Call your vet promptly if your donkey seems weak, unusually sleepy, unsteady, stops eating, develops diarrhea, or shows signs of abdominal pain after treatment. See your vet immediately for collapse, severe incoordination, repeated rolling, trouble standing, or any rapidly worsening signs. Risk may be higher in very young, underweight, or debilitated animals, and in animals that were dosed inaccurately.

Published donkey-specific interaction data are limited, so your vet will usually take a cautious, whole-patient approach. In general, moxidectin should be used carefully with other medications that may affect the nervous system, and with other antiparasitic products unless your vet specifically recommends the combination.

If your donkey is receiving another dewormer, sedatives, anti-inflammatory drugs, or treatment for another illness, tell your vet before dosing. This is especially important if your donkey is sick, dehydrated, underweight, pregnant, or nursing.

Also mention any recent deworming history. Using the wrong product too close together, or combining products without a plan, can increase the chance of side effects or make it harder to judge whether a treatment worked. Your vet can help you choose a schedule that balances parasite control, resistance concerns, and safety.